Uppsala, Sweden - March 21, 2019 – Orexo’s Annual Report, including the Sustainability Report, for the 2018 fiscal year has been published and can be downloaded on the company’s website, www.orexo.com (investors/reports, presentations and audiocasts). A PDF version is also attached to t... read more

March 21, 2019Non-regulatory Due to the significant interest among investors and the impact on MIPS’ share price as a result of information in media about bike gear company Bontrager’s new helmets equipped with a new helmet technology called “WaveCel”, MIPS has elected to comment on... read more

Pfizer and Vivet to collaborate on development of potential breakthrough therapy for Wilson disease Pfizer acquires 15% ownership stake in Vivet Paris, France and New York, US, March 20, 2019 – Vivet Therapeutics (“Vivet”), a privately held gene therapy biotech company dedicated to devel... read more

Seroprotective HAI antibody response persisted more than one year after vaccination Company seeking partnership for further development and commercialization of NasoVAX GAITHERSBURG, Md., March 19, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics comp... read more

Thursday, March 14, 2019 Targovax grants Zelluna an FTO license to Targovax patents and know-how to further enable development of Zelluna’s mutant RAS T-cell receptor therapies Targovax and Zelluna intend to collaborate on additional discovery and development of novel mutant RAS T ... read more